Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease
Authors
Discussion
Loading...
Member takes
Implication
Randomized trial assesses MMP-9 as a predictor of mortality in coronary artery disease, indicating potential for improved prognosis.
Key Points
- To evaluate plasma MMP-9 concentrations as a predictor of cardiovascular mortality in coronary artery disease patients.
- Assessment of plasma MMP-9 concentration alongside other inflammatory markers in a clinical setup.
- Comparison of MMP-9 predictive value for mortality against existing markers.
- Plasma MMP-9 concentration was associated with increased cardiovascular mortality.
- The study suggests that MMP-9 may offer independent prognostic information alongside other markers.
Cite This Study
Blankenberg et al. (2003) studied this question.